BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Spartex who wrote (384)	5/7/1999 12:48:00 PM
From: DWIGHT	of 534

Quad Nice to hear from some one that truly knows the problems that we are faced w/ 24 hours a day 7 days a week. Being insulin dependent makes the glucose monitor an invaluable tool. Non envaseive makes it almost beyond reality. I do think Bioject (BJCT) w/ their venture w/ Elan To make the Glucowatch, are the front runners in this science. Also, w/ FDA approval (bjct) could be a company w/ phenominal EPS and $40/$50 share price tag. I'll let you know when this hits the market. If you monitor bjct share price, you will know when they get FDA approval. And the best to you! DWIGHT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next